The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Novartis (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst)
Expert Testimony - Abbvie
Comparison of real-world treatment patterns, persistence, healthcare resource utilization (HRU) and costs between octreotide and lanreotide for the treatment of neuroendocrine tumors (NET).
 
Lynn Huynh
Research Funding - Novartis (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst)
 
Beilei Cai
Employment - Novartis
Stock and Other Ownership Interests - Novartis
Research Funding - Novartis
Travel, Accommodations, Expenses - Novartis
 
Camara Sharperson
Research Funding - Novartis (Inst)
 
Dominique Lejeune
Research Funding - Eisai (Inst); GlaxoSmithKline (Inst); Janssen Scientific Affairs (Inst); Novartis (Inst)
 
Mei Sheng Duh
No Relationships to Disclose
 
Michelle Kang Kim
Consulting or Advisory Role - Lexicon; Novartis
Research Funding - Ipsen
Travel, Accommodations, Expenses - Lexicon